Radient Technologies Inc V.RTI.H

Alternate Symbol(s): RDDTF

Radient Technologies Inc. is a science-based company. The Company is a commercial manufacturer of cannabinoid-based formulations, ingredients, and products. The principal activities of the Company and its subsidiaries are engaged in research, development, and commercialization of an efficient and environmentally responsible technology for the extraction, isolation, and purification of soluble products from a range of materials using microwave technology and a customized hydrocarbon extraction platform. The Company is focused on the formulation, manufacturing and launching of value-added cannabis products. It utilizes a proprietary extraction and downstream processing platform that recovers up to 99% of cannabinoids from the cannabis plant. It develops specialty products and ingredients that contain a range of cannabinoid and terpene profiles.

TSXV:RTI.H - Post by User

Radient Technologies Inc

Bullboard Posts

Post by TropWeston May 16, 2017 10:42pm

190 Views

Post# 26253037

MJ Companies Leveraging Biotech Enhancements to Boost Purity

16 MAY 2017 BY MACIEJ HEYMAN

Cannabis Companies Leveraging Biotech Enhancements to Boost Improved Purity of Medicinal Marijuana Treatments and Products

PALM BEACH, Florida, May 16, 2017 /PRNewswire/ —

The influence of biotech advancements in the cannabis industries continues to be apparent as more and more companies focus upon various aspects of biotechnology to enhance operations and in turn boost revenues. With a growing population and finite natural resources, the challenge to produce higher quality therapies, treatment and increasing the purity of legal marijuana products while protecting the consumer is real while advances in biotechnology are quickly becoming a vital tool to help the legal medical marijuana industry get there.

Radient Technologies Inc. (TSX-V: RTI.V) (OTC: RDDTF) closed up over 16% at $0.56 on Monday trading over 3.6 Million shares on the Canadian TSX Venture exchange by the market close. Radient Technologies announced yesterday the completion of the second phase of its previously announced joint venture research agreement with Aurora Cannabis Inc. (TSX-V: ACB. V)(OTCQX ACBFF). As previously announced, Radient and Aurora entered into a memorandum of understanding (‚MOU’) with regard to the exclusive joint development and commercialization of superior and standardized cannabinoid extracts for the Canadian market. In accordance with the MOU, the parties entered into a joint venture research agreement to confirm the effectiveness of Radient’s MAP™ technology for cannabis extraction.

Article Link